We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Intel
INTC
$499B
| $421M | 0.16% |
15,936,661
-627,335
| -4% | -$17.4M |
|
127
CVS Health
CVS
$123B
| $418M | 0.16% |
4,484,865
-469,207
| -9% | -$45.3M |
|
128
MetLife
MET
$62.5B
| $416M | 0.16% |
5,749,682
-965,163
| -14% | -$69.1M |
|
129
Edwards Lifesciences
EW
$51.9B
| $404M | 0.16% |
5,419,476
-141,672
| -3% | -$10.9M |
|
130
Stryker
SYK
$130B
| $396M | 0.15% |
1,619,244
+399,892
| +33% | +$90.7M |
|
131
CSX Corp
CSX
$93.3B
| $393M | 0.15% |
12,685,891
-455,088
| -3% | -$13.7M |
|
132
Progressive
PGR
$125B
| $382M | 0.15% |
2,948,786
+377,596
| +15% | +$47.8M |
|
133
Citigroup
C
$226B
| $381M | 0.15% |
8,419,840
+93,896
| +1% | +$4.27M |
|
134
Sherwin-Williams
SHW
$89.9B
| $375M | 0.15% |
1,579,653
-390,499
| -20% | -$90.3M |
|
135
Public Storage
PSA
$61.5B
| $374M | 0.15% |
1,336,045
-13,274
| -1% | -$3.87M |
|
136
Uber
UBER
$153B
| $372M | 0.14% |
15,044,232
+260,244
| +2% | +$7.12M |
|
|
BNY
137
Bank of New York Mellon
BNY
$107B
| $368M | 0.14% |
8,085,500
+3,083,746
| +62% | +$132M |
|
138
WEC Energy
WEC
$35.3B
| $364M | 0.14% |
3,879,659
+375,327
| +11% | +$34.7M |
|
|
FISV
139
Fiserv Inc
FISV
$27.8B
| $361M | 0.14% |
3,571,797
+87,276
| +3% | +$8.69M |
|
140
W.W. Grainger
GWW
$60.9B
| $359M | 0.14% |
645,878
+96,514
| +18% | +$54.5M |
|
141
Dollar General
DG
$27.9B
| $358M | 0.14% |
1,455,494
+670,349
| +85% | +$166M |
|
142
Dover
DOV
$28.7B
| $354M | 0.14% |
2,611,629
+4,330
| +0.2% | +$575K |
|
143
Humana
HUM
$45.8B
| $353M | 0.14% |
689,820
-248,558
| -26% | -$131M |
|
144
SLB Ltd
SLB
$76B
| $350M | 0.14% |
6,553,061
-571,276
| -8% | -$28.4M |
|
145
Phillips 66
PSX
$81.1B
| $350M | 0.14% |
3,362,418
+211,712
| +7% | +$21.7M |
|
146
Diamondback Energy
FANG
$52.3B
| $346M | 0.13% |
2,531,410
+187,641
| +8% | +$27.4M |
|
147
Analog Devices
ADI
$189B
| $343M | 0.13% |
2,090,471
-48,443
| -2% | -$7.56M |
|
148
Lockheed Martin
LMT
$134B
| $343M | 0.13% |
704,067
+23,940
| +4% | +$11.1M |
|
149
Freeport-McMoran
FCX
$96.7B
| $342M | 0.13% |
8,990,072
+628,368
| +8% | +$22M |
|
150
Verisk Analytics
VRSK
$25.2B
| $339M | 0.13% |
1,919,574
-68,022
| -3% | -$12M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.